Evidence map›Paper›PMID 42521938›Full record

ReviewTropical animal health and production2026

Recent advancements in phytotherapeutics for controlling babesiosis and theileriosis.

Amar Prajapati, Ritika Rajput, Anand Srivastava

Abstract readReview
PubMed Publisher
In one paragraph

Review in Tropical animal health and production, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pomegranate (Veterinary sciences · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Amar PrajapatiBiotechnology Research Innovation Council-National Institute of Animal Biotechnology (BRIC-NIAB), Gachibowli, Hyderabad, Telangana, 500032, India.
Ritika RajputBiotechnology Research Innovation Council-National Institute of Animal Biotechnology (BRIC-NIAB), Gachibowli, Hyderabad, Telangana, 500032, India.
Anand SrivastavaBiotechnology Research Innovation Council-National Institute of Animal Biotechnology (BRIC-NIAB), Gachibowli, Hyderabad, Telangana, 500032, India. anand@niab.org.in.ORCID http://orcid.org/0000-0002-2031-4643

Funding

Department of Biotechnology, Ministry of Science and Technology, India BT/PR42271/TRM/120/511/2021ICMR 3/1/3/JRF-2020/HRD(LS)/134663/49University Grants Commission 211610035458
6 · The paper itself

Abstract

Babesiosis/theileriosis is a tick-borne disease caused by protozoan parasites of the genus Babesia and Theileria. Tick species of genera, such as Ixodes, Rhipicephalus, Haemaphysalis and Hyalomma, transmit these parasites. These diseases threaten livestock productivity and health, particularly in tropical and subtropical areas. These diseases have a significant economic impact due to reduced milk and meat production, reproductive losses, higher veterinary expenses, and, in extreme cases, animal mortality. Even after decades of research, piroplasmosis is still difficult to control and manage. The most common drugs to treat this disease include buparvaquone, diminazene aceturate, and imidocarb dipropionate. These drugs are known for toxicity, and recent reports of the emergence of resistance to these drugs are worrisome. Hence, the development of alternative sustainable control methods is necessary. This review examines the current status of research on plant-based natural extracts/compounds, with particular emphasis on combination therapies integrating natural products with synthetic antiparasitic agents.

Indexed as

Antiprotozoal AgentsBabesiosisPhytotherapyPlant ExtractsTheileriasisAnimalsAntiparasitic AgentsBabesiaTheileriaAntiparasitic AgentsAntiprotozoal AgentsPlant ExtractsBabesiosisControl strategiesDrugsPiroplasmosisPlant extractsTheileriosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.